Therapeutic Catalyst
Supports global cancer teams through CRUK to validate novel therapeutic concepts toward patient solutions.
Cancer Research UK's Therapeutic Catalyst scheme accelerates the translation of laboratory discoveries into novel cancer therapeutics by funding exploratory drug discovery projects focused on validating and de-risking therapeutic targets. Two award types are available: Target Award (up to £250,000 over 12-18 months) and Early Therapy Award (up to £350,000 over 18-24 months) and cover external reso…
Cancer therapeutic target identification, deconvolution, and validation, plus feasibility work on novel therapeutic approaches to validated targets, conducted in collaboration with Cancer Research Horizons.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
BudgetGrant Budget Justification: How to Write the Budget Narrative
Learn how to write a grant budget justification, explain R&D costs, avoid weak budget narratives, and connect each cost to your work plan.
More from CRUK
All grants from this funder →Biology to Prevention Award — B
🇬🇧CRUK · United Kingdom
Supports mechanistic prevention research in the United Kingdom with early career fellowships for practical development.
Black Leaders in Cancer Scholarship Programme
🇬🇧CRUK · United Kingdom
Fully funds a 4-year cancer research PhD for applicants who self-identify as Black heritage.
Clinical Research Funding Scheme — B
🇬🇧CRUK · United Kingdom
Supports United Kingdom clinical teams through CRUK grants that progress studies from pilot concepts to trials.
Discovery Programme Award — B outline)
🇬🇧CRUK · United Kingdom
Supports United Kingdom cancer science programmes with multi-stage funding for innovation in disease biology.
Drug Development Project
CRUK · United Kingdom
Sponsors and directly runs cancer drug development, in place of a cash grant.
Early Detection and Diagnosis Programme Award — B
🇬🇧CRUK · United Kingdom
Supports cancer detection and diagnosis innovation in the United Kingdom through transformational early development programmes.
Similar grants
Browse the directory →
NIH IGNITE Program — R61/R33 Phased Neurotherapeutic Grants
🇺🇸NIH · United States
Supports early neurotherapeutic translation through milestone-based translational funding.
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy
🇺🇸NIH · United States
Funds work combining imaging with liquid biopsy during cancer treatment, to see sooner whether it is working or resistance is emerging.
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research
🇺🇸NIH · United States
Funds rigorously validating a transformative, multi-use platform or technology aimed at heart, lung, blood or sleep disease.
NRC IRAP Standard R&D Contribution
🇨🇦NRC · Canada
Provides Canadian innovators with hands-on guidance for technology-led projects and commercialization planning.
Eurostars Call 11 (UK)
🇬🇧Innovate UK · United Kingdom
Funds United Kingdom firms in multinational innovation consortia for export readiness.
NIDCD Research Grants for Translating Basic Research into Clinical Practice
NIH · United States
Funds translational research turning basic findings into clinical tools for communication disorders, with practical clinical impact required.